Global Patent Index - EP 4370101 A1

EP 4370101 A1 20240522 - A PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE FOR THE TREATMENT OF HYPERTENSION

Title (en)

A PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE FOR THE TREATMENT OF HYPERTENSION

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT AMLODIPIN, CANDESARTAN-CILEXETIL UND HYDROCHLORTHIAZID ZUR BEHANDLUNG VON BLUTHOCHDRUCK

Title (fr)

COMPOSITION PHARMACEUTIQUE COMPRENANT DE L'AMLODIPINE, DU CANDÉSARTAN CILEXETIL ET DE L'HYDROCHLOROTHIAZIDE POUR LE TRAITEMENT DE L'HYPERTENSION

Publication

EP 4370101 A1 20240522 (EN)

Application

EP 22751065 A 20220715

Priority

  • EP 21185961 A 20210715
  • EP 2022069840 W 20220715

Abstract (en)

[origin: WO2023285646A1] The present invention relates to fixed dose pharmaceutical compositions in the form of hard capsules comprising Amlodipine, Candesartan cilexetil and Hydrochlorothiazide for the treatment of hypertension.

IPC 8 full level

A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 31/4184 (2006.01); A61K 31/4422 (2006.01); A61K 31/549 (2006.01); A61K 47/36 (2006.01)

CPC (source: EP)

A61K 9/1641 (2013.01); A61K 9/4866 (2013.01); A61K 31/4184 (2013.01); A61K 31/4422 (2013.01); A61K 31/549 (2013.01); A61K 47/36 (2013.01)

C-Set (source: EP)

  1. A61K 31/4184 + A61K 2300/00
  2. A61K 31/4422 + A61K 2300/00
  3. A61K 31/549 + A61K 2300/00

Citation (search report)

See references of WO 2023285646A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2023285646 A1 20230119; EP 4370101 A1 20240522

DOCDB simple family (application)

EP 2022069840 W 20220715; EP 22751065 A 20220715